BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Diagnosis
352 results:

  • 1. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
    Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
    J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Outcomes of the patients with metastatic male breast cancer.
    Dogan I; Khanmammadov N; Ozkurt S; Aydiner A; Saip P
    J Cancer Res Ther; 2024 Jan; 20(1):98-102. PubMed ID: 38554305
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
    Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
    Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [A Case of Breast cancer That Developed Pulmonary Tumor Thrombotic Microangiopathy during Adjuvant Chemotherapy].
    Okano K; Suzuki T; Abe A; Itaya A; Kameyama Y; Matsumoto S; Hakamada K
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):283-285. PubMed ID: 38494809
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Role of
    Chu J; Tang S; Li T; Fan H
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):73. PubMed ID: 38420798
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
    Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
    BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. miRNA-449c-5p regulates the JAK-STAT pathway in inhibiting cell proliferation and invasion in human breast cancer cells by targeting erbb2.
    Li L; Zhang Y; Yang K; Liu W; Zhou Z; Xu Y
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1974. PubMed ID: 38351535
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Deciphering the heterogeneity of neutrophil cells within circulation and the lung cancer microenvironment pre- and post-operation.
    Liu F; Liu X; Liu Y; Chen D; Liu X; Qin C; Song Y; Fang H; Wu D
    Cell Biol Toxicol; 2024 Feb; 40(1):11. PubMed ID: 38319415
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [A Case of Complete Remission in a Patient with Synchronous Double cancers of the Breast and lung].
    Hayakawa T; Hasegawa K; Maejima K; Takatsuno Y; Kaneko J; Higashi Y; Isogai J; Tagawa K; Yoshida H
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1459-1461. PubMed ID: 38303307
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [A Case of Triple Negative Breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
    Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. lung toxicity induced by anti-her2 antibody - drug conjugates for breast cancer.
    Chai M; Li L; Wu H; Liu Y; Yi Z; Yu H
    Crit Rev Oncol Hematol; 2024 Mar; 195():104274. PubMed ID: 38295890
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]    [Full Text] [Related]  

  • 13. [A Case of Severe Drug-Induced lung Injury during Preoperative Chemotherapy for Breast cancer in the Early Stages of the COVID-19 Epidemic].
    Hirata A; Terasawa R; Takashima Y; Morita S; Kimura K; Iwamoto M; Hayashi M
    Gan To Kagaku Ryoho; 2023 Dec; 50(12):1343-1345. PubMed ID: 38247078
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Link between m6A modification and infiltration characterization of tumor microenvironment in lung adenocarcinoma.
    Yang S; Li K; Zhang J; Liu J; Liu L; Tan Y; Xu C
    Exp Biol Med (Maywood); 2023 Dec; 248(23):2273-2288. PubMed ID: 38166412
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparison of Clinical and Genetic Characteristics Between Younger and Older lung cancer Patients.
    Candal-Pedreira C; Ruano-Ravina A; Calvo de Juan V; Cobo M; Trigo JM; Rodríguez-Abreu D; Estival A; Carcereny E; Cucurull M; López Castro R; Medina A; García Campelo R; Cordeiro González P; Sánchez-Gastaldo A; Bosch-Barrera J; Massutí B; Dómine M; Camps C; Ortega AL; Sánchez-Hernández A; Guirado Risueño M; Del Barco Morillo E; Garrido Fernández A; Provencio M
    Arch Bronconeumol; 2024 Feb; 60(2):88-94. PubMed ID: 38160163
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cardiovascular sequelae of trastuzumab and anthracycline in long-term survivors of breast cancer.
    Glen C; Morrow A; Roditi G; Hopkins T; Macpherson I; Stewart P; Petrie MC; Berry C; Epstein F; Lang NN; Mangion K
    Heart; 2024 Apr; 110(9):650-656. PubMed ID: 38103912
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A Case Report of a Rare ER+, PR- Pure Metaplastic Breast Squamous Cell Carcinoma with her2 Overexpression.
    Adam SA; Kamaruddin KN; Abd Shukor N; Abdullah Suhaimi SN; Ismail F; Md Yasin M
    Am J Case Rep; 2023 Dec; 24():e941448. PubMed ID: 38048289
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Association between ER, PR, her2, and ER-/PR+ Expression and lung cancer Subsequent in Breast cancer Patients: A Retrospective Cohort Study Based on SEER Database.
    Shao HY; Hao BT; Gao FX
    Breast J; 2023; 2023():7028189. PubMed ID: 38021219
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Multidisciplinary clinical guidelines in proactive monitoring, early diagnosis, and effective management of trastuzumab deruxtecan (T-DXd)-induced interstitial lung disease (ILD) in breast cancer patients.
    Wekking D; Porcu M; Pellegrino B; Lai E; Mura G; Denaro N; Saba L; Musolino A; Scartozzi M; Solinas C
    ESMO Open; 2023 Dec; 8(6):102043. PubMed ID: 37951130
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK lung Panel on the MassARRAY System in Metastatic Non-Small Cell lung cancer Patients.
    Leest PV; Janning M; Rifaela N; Azpurua MLA; Kropidlowski J; Loges S; Lozano N; Sartori A; Irwin D; Lamy PJ; Hiltermann TJN; Groen HJM; Pantel K; Kempen LCV; Wikman H; Schuuring E
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686200
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 18.